Genetic Changes in Breast Cancer and Their Impact on Prognosis
Author Information
Author(s): M.A. Nagai, M.M. Pacheco, M.M. Brentanil, L.A. Marques, R.R. Brentani, B.A.J. Ponder, L.M. Mulligan
Primary Institution: Disciplina de Oncologia da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
Hypothesis
Is allelic loss on distal chromosome 17p associated with poor prognosis in Brazilian breast cancer patients?
Conclusion
Patients with loss of heterozygosity for D17S5 have a higher risk of recurrence compared to those who retain heterozygosity.
Supporting Evidence
- Patients with LOH for D17S5 had a significantly shorter disease-free interval.
- Kaplan-Meier analyses indicated a higher risk of recurrence for patients with LOH for D17S5.
- Patients with both LOH for D17S5 and erbB-2 amplification had the worst prognosis.
Takeaway
This study found that some genetic changes in breast cancer can help doctors predict how likely a patient is to get better or worse.
Methodology
The study analyzed primary breast cancer samples for loss of heterozygosity at specific loci on chromosome 17p and erbB-2 gene amplification.
Limitations
The study had a relatively short follow-up period and did not consider the effects of adjuvant systemic treatments.
Participant Demographics
The study included 29 premenopausal and 38 postmenopausal Brazilian women aged 30-82.
Statistical Information
P-Value
0.007
Statistical Significance
p=0.007
Want to read the original?
Access the complete publication on the publisher's website